Aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis : reassuring data.
Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis.
Rédigé par : Dr Philippe Lesprit
Aminoglycosides are usually recommended only as second line therapy for the treatment of acute pyelonephritis. However they offer several advantages in the treatment of urinary tract infections (UTI), including good in vitro activity against most uropathogens, including many ESBL producing organisms, favorable urinary tract pharmacokinetics resulting in adequate renal and urine drug levels and ...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.